AstraZeneca (AZ) has announced that its Imfinzi (durvalumab)-based perioperative regimen has been approved by the European ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Dizal’s Zegfrovy (sunvozertinib) to treat a ...

Early commercialisation is one of the most demanding stages in bringing a therapy to market, and the challenges are only ...

Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).

Biogen has announced that it has initiated a phase 3 study of investigational felzartamab in adults with primary membranous ...

A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of ...

“ [These] strong phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in ...

The European Commission (EC) has granted conditional approval to Jazz Pharmaceuticals’ Ziihera (zanidatamab) to treat a ...

Camera fatigue: being on camera means always being on show. This can be distracting for some individuals who are constantly ...

Implementing AI in regulated industries like healthcare requires more than advanced technology. It demands strategic ...

Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

The Communiqué Awards returned for its 27th year on 3 July to celebrate excellence in healthcare communications and showcase ...